Syndax Pharmaceuticals Inc Banner Image

Syndax Pharmaceuticals Inc has reached its limit for free report views

Work for Syndax Pharmaceuticals Inc? Upgrade Your Profile and unlock all your annual reports.

Syndax Pharmaceuticals Inc

  • Ticker SNDX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Syndax Pharmaceuticals Inc Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Syndax is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Company lead product candidate, entinostat, which was granted Breakthrough Therapy designation by the FDA following positive results from our Phase 2b clinical trial, ENCORE 301, is currently being evaluated in a Phase 3 clinical trial for advanced hormone receptor positive, humanMore epidermal growth factor receptor 2 negative breast cancer.
Syndax Pharmaceuticals Inc

Most Recent Annual Report

Syndax Pharmaceuticals Inc MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Syndax Pharmaceuticals Inc has reached its limit for free report views.

Syndax Pharmaceuticals Inc does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports